UC San Diego researchers describe the underlying signaling pathway that results in pulmonary arterial hypertension and a novel monoclonal antibody therapy that blocks the abnormal blood vessel formation characterizing the disease.
Related Articles

News
Monitors and Meddlers
Lauren Prather’s new book “Monitors and Meddlers: How Foreign Actors Influence Local Trust in Elections” has been a long time in the making—a full decade, in fact.
[…]

News
San Diego Supercomputer Center’s Expanse Provides a Sneak Peek of the Extended Solar Corona
December 3, 2021
sandiegobiotech
News, UCSD News
Comments Off on San Diego Supercomputer Center’s Expanse Provides a Sneak Peek of the Extended Solar Corona
On Saturday, Dec. 4, a total eclipse of the sun will occur at 07:33 (Universal Time) over Antarctica and parts of the South Pacific near the southern tip of Chile. The solar corona – visible to the naked eye onl… […]

News
UC San Diego Heart Transplant Program Boasts Nation?s Best Survival Rates
August 7, 2019
sandiegobiotech
News
Comments Off on UC San Diego Heart Transplant Program Boasts Nation?s Best Survival Rates